Putters, F. (08 December 2025). Mechanistic study of the antivirulence activity of ticagrelor against Staphylococcus aureus at antiplatelet dosage [Poster presentation]. Annual meeting Belgian working group - Basic research in Cardiology (BWG-BRC), Ghent, Belgium. |
Putters, F. (27 November 2025). Mechanistic study of the antivirulence activity of ticagrelor against Staphylococcus aureus at antiplatelet dosage [Paper presentation]. Annual Meeting of the Belgian Society on Thrombosis and Haemostasis (BSTH), Mechelen, Belgium. |
Leeten, K., Jacques, N., Esquembre, L. A., Schneider, D. C., Straetener, J., Henriksen, C., MUSUMECI, L., Putters, F., Ferreira Melo, S., Sánchez-López, E., Giera, M., Penoy, N., Piel, G., Verlaine, O., Amoroso, A., Joris, B., Slavetinsky, C. J., Goffin, E., Pirotte, B., ... Oury, C. (2024). Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance. MBio, 0132224. doi:10.1128/mbio.01322-24 |
Putters, F. (2024). Characterization of the antibacterial activity of ticagrelor against resistant Staphylococcus aureus strains: comparison and interaction with daptomycin and vancomycin [Master’s dissertation, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/329429 |